Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia

被引：19

作者：

Ghoshal Gupta, Ampa ^{[1
]}

Baumann, Heinz ^{[2
]}

Wetzler, Meir ^{[1
]}

机构：

[1] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA

[2] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA

来源：

LEUKEMIA RESEARCH | 2008年 / 32卷 / 07期

关键词：

signal transducer and activator of transcription 3; hypermethylation; acute myeloid leukemia;

D O I：

10.1016/j.leukres.2007.11.035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We have demonstrated that constitutive signal transducer and activator of transcription (STAT) 3 activity, observed in approximately 50% of acute myeloid leukemia (AML) cases, is associated with adverse treatment outcome. Constitutive STAT3 activation may result from the expression of oncogenic protein tyrosine kinases or from autocrine stimulation by hematopoietic growth factors. These causes are generally neither necessary nor sufficient for leukemogenesis; additional transforming events or growth stimulatory processes are needed. Here we review the literature addressing epigenetic regulation as a mechanism controlling STAT3 signaling in AML. A better understanding of mechanisms of dysregulation of STAT signaling pathways may serve as a basis for designing novel therapeutic strategies that target these pathways in leukemia cells. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：1005 / 1014

页数：10

共 90 条

[1] NUMBER OF CPG ISLANDS AND GENES IN HUMAN AND MOUSE [J].

ANTEQUERA, F ;

BIRD, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11995-11999

[2] Phase I trial of continuous infusion 5-aza-2′-deoxycytidine [J].

Aparicio, A ;

Eads, CA ;

Leong, LA ;

Laird, PW ;

Newman, EM ;

Synold, TW ;

Baker, SD ;

Zhao, M ;

Weber, JS .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (03) :231-239

[3]

Baylin SB, 1998, ADV CANCER RES, V72, P141

[4] Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival [J].

Benekli, M ;

Xia, Z ;

Donohue, KA ;

Ford, LA ;

Pixley, LA ;

Baer, MR ;

Baumann, H ;

Wetzler, M .

BLOOD, 2002, 99 (01) :252-257

[5] Signal transducer and activator of transcription proteins in leukemias [J].

Benekli, M ;

Baer, MR ;

Baumann, H ;

Wetzler, M .

BLOOD, 2003, 101 (08) :2940-2954

[6] DNA methylation controls the responsiveness of hepatoma cells to leukemia inhibitory factor [J].

Blanchard, F ;

Tracy, E ;

Smith, J ;

Chattopadhyay, S ;

Wang, YP ;

Held, WA ;

Baumann, H .

HEPATOLOGY, 2003, 38 (06) :1516-1528

[7] The suppressor of cytokine signalling-1 (SOCS-1) gene is overexpressed in Philadelphia chromosome negative chronic myeloproliferative disorders [J].

Bock, Oliver ;

Hussein, Kais ;

Brakensiek, Kai ;

Buhr, Thomas ;

Schlue, Jerome ;

Wiese, Birgitt ;

Kreipe, Hans .

LEUKEMIA RESEARCH, 2007, 31 (06) :799-803

[8] Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome [J].

Brakensiek, K ;

Länger, F ;

Schlegelberger, B ;

Kreipe, H ;

Lehmann, U .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (02) :209-217

[9] MicroRNAs and chromosomal abnormalities in cancer cells [J].

Calin, G. A. ;

Croce, C. M. .

ONCOGENE, 2006, 25 (46) :6202-6210

[10] Ubiquitous activation of Ras and Jak/Stat pathways in human HCC [J].

Calvisi, DF ;

Ladu, S ;

Gorden, A ;

Farina, M ;

Conner, EA ;

Lee, JS ;

Factor, VM ;

Thorgeirsson, SS .

GASTROENTEROLOGY, 2006, 130 (04) :1117-1128

← 1 2 3 4 5 6 7 8 9 →